We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
+15.5%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$2.94B
AUM Growth
+$354M
(+14%)
Cap. Flow
+$71.5M
Cap. Flow
% of AUM
2.43%
Top 10 Holdings %
Top 10 Hldgs %
43.94%
Holding
91
New
27
Increased
20
Reduced
25
Closed
12
Top Buys
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$85.5M |
| 2 |
uniQure
QURE
|
+$52M |
| 3 |
Labcorp
LH
|
+$50.7M |
| 4 |
Xeris Biopharma Holdings
XERS
|
+$46.9M |
| 5 |
InflaRx
IFRX
|
+$40.6M |
Top Sells
| 1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
+$78.7M |
| 2 |
Puma Biotechnology
PBYI
|
+$74.6M |
| 3 |
Penumbra
PEN
|
+$67.6M |
| 4 |
Abbott
ABT
|
+$39.2M |
| 5 |
Regenxbio
RGNX
|
+$27.2M |
Sector Composition
| 1 | Healthcare | 93.19% |
| 2 | Financials | 1.03% |
| 3 | Technology | 0% |
| 4 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $268M | 9.11% |
15,978,580
-1,245,848
| -7% | -$19.8M |
|
|
FOLD
2
DELISTED
Amicus Therapeutics
FOLD
| $164M | 5.58% |
10,511,732
-226,926
| -2% | -$3.43M |
|
3
Atara Biotherapeutics
ATRA
$76.6M
| $152M | 5.15% |
165,065
-4,376
| -3% | -$4.7M |
|
|
IMGN
4
DELISTED
Immunogen Inc
IMGN
| $120M | 4.07% |
12,315,942
+2,613,460
| +27% | +$27.6M |
|
5
Xencor
XNCR
$1.08B
| $116M | 3.96% |
3,147,043
-57,300
| -2% | -$1.97M |
|
|
6
Regenxbio
RGNX
$592M
| $112M | 3.81% |
1,561,175
-569,797
| -27% | -$27.2M |
|
|
ALDR
7
DELISTED
Alder Biopharmaceuticals
ALDR
| $103M | 3.49% |
6,505,766
| – | – |
|
|
WCG
8
DELISTED
Wellcare Health Plans, Inc.
WCG
| $87.4M | 2.97% |
355,009
+12,700
| +4% | +$2.77M |
|
9
Wave Life Sciences
WVE
$1.11B
| $85.9M | 2.92% |
2,244,507
+6,900
| +0.3% | +$297K |
|
|
BOLD
10
DELISTED
Audentes Therapeutics, Inc
BOLD
| $85.2M | 2.89% |
2,228,656
+920,130
| +70% | +$34.1M |
|
|
CLVS
11
DELISTED
Clovis Oncology, Inc.
CLVS
| $80M | 2.72% |
+1,758,600
| New | +$85.5M |
|
12
Fate Therapeutics
FATE
$322M
| $75.5M | 2.56% |
6,655,962
| – | – |
|
|
13
InflaRx
IFRX
$295M
| $65.4M | 2.22% |
2,027,700
+1,176,600
| +138% | +$40.6M |
|
14
Centene
CNC
$32.6B
| $62.6M | 2.13% |
1,015,970
-103,630
| -9% | -$5.98M |
|
|
15
uniQure
QURE
$2.76B
| $61.4M | 2.09% |
+1,624,400
| New | +$52M |
|
|
ALXN
16
DELISTED
Alexion Pharmaceuticals
ALXN
| $60.7M | 2.06% |
489,300
+84,500
| +21% | +$9.88M |
|
17
LivaNova
LIVN
$4.52B
| $59.9M | 2.03% |
599,788
+81,500
| +16% | +$7.4M |
|
|
DCPH
18
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $58.1M | 1.97% |
1,477,080
+655,800
| +80% | +$19.3M |
|
19
argenx
ARGX
$53.7B
| $55.8M | 1.9% |
673,300
+434,700
| +182% | +$38.9M |
|
20
ICU Medical
ICUI
$4.06B
| $54.1M | 1.84% |
184,172
-9,300
| -5% | -$2.54M |
|
|
21
Labcorp
LH
$22.5B
| $51.8M | 1.76% |
+335,698
| New | +$50.7M |
|
22
Insmed
INSM
$23B
| $48.1M | 1.63% |
2,033,492
-132,870
| -6% | -$3.42M |
|
|
SYNH
23
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $46M | 1.56% |
981,673
-544,431
| -36% | -$22.5M |
|
|
24
Xeris Biopharma Holdings
XERS
$1.52B
| $45.8M | 1.56% |
+2,412,642
| New | +$46.9M |
|
|
BLUE
25
DELISTED
bluebird bio
BLUE
| $42.1M | 1.43% |
20,728
+108
| +0.5% | +$246K |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO